THYTECH

THYTECH

Transferring to the patient it's patented technology for the treatment of diseases related to immune disorders.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD2—4m (Dealroom.co estimates Apr 2022.)
Company register number B67989202
Madrid Community of Madrid (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2023
Revenues<1m
  • Edit
DateInvestorsAmountRound
-

N/A

-
*

€350k

Seed

N/A

Spinout
Total FundingAUD595k

Recent News about THYTECH

Edit